Trade Gilead ^GILD

Top Pharmaceutical Stocks To Keep An Eye On - May 17th - Stock Observer

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline

Leuthold Group LLC Boosts Stake in Gilead Sciences, Inc. $GILD

L & S Advisors Inc Invests $5.09 Million in Gilead Sciences, Inc. $GILD

STF Management LP Sells 11,745 Shares of Gilead Sciences, Inc. $GILD

iA Global Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Canada Post Corp Registered Pension Plan

Abacus Wealth Partners LLC Buys Shares of 12,486 Gilead Sciences, Inc. $GILD

Bank Julius Baer & Co. Ltd Zurich Sells 4,174 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by STF Management LP - Daily Political

AlphaCore Capital LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Position Lessened by Canada Post Corp Registered Pension Plan - Daily Political

Abacus Wealth Partners LLC Makes New $1.53 Million Investment in Gilead Sciences, Inc. $GILD - Daily Political

Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority Review

Lawood & Co. Invests $633,000 in Gilead Sciences, Inc. $GILD - Zolmax

A Look At Gilead Sciences (GILD) Valuation After The Recent Share Price Pullback

Gilead Sciences, Inc. $GILD Shares Acquired by Commerzbank Aktiengesellschaft FI

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Yield-Hungry Investors Bet on Credit as Government Debt Sours

Gilead Sciences (GILD) Prices $3B Senior Unsecured Notes Offering

Arbejdsmarkedets Tillaegspension Takes Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - Daily Political

Company Website: https://www.gilead.com/ FOSTER CITY, Cali

Gilead Prices $3 Billion of Senior Unsecured Notes

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

Gilead Liver Data At EASL Tests Case For A Third Growth Pillar

PRMT5 inhibitors detailed in Gilead Sciences patent | BioWorld

Top Pharmaceutical Stocks To Watch Now - May 13th - Daily Political

Trek Financial LLC Purchases 13,041 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Stock Observer

Gilead Sciences Inc at Bank of America Global Healthcare Conference Transcript

Promising Medical Stocks Worth Watching - May 9th - Stock Observer

Money Concepts Capital Corp Sells 4,126 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Bailard Inc. Has $90.10 Million Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs

LA500 2026: Arie Belldegrun

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

Kepler Cheuvreux Suisse SA Acquires New Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Acquired by ABN AMRO Bank N.V.

Swiss Life Asset Management Ltd Reduces Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Royal Bank Of Canada Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $122.00 - Stock Observer

Did Gilead's Mixed Q1, Buybacks and HIV Milestone Just Shift Gilead Sciences' (GILD) Investment Narrative? - Simply Wall St News

Gilead Sciences (GILD) Receives a Buy from Citi

NewEdge Wealth LLC Grows Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Promising Pharmaceutical Stocks To Watch Now - May 9th - Stock Observer

Gilead Sciences (NASDAQ:GILD) Price Target Lowered to $146.00 at Leerink Partners - Zolmax

Leerink Partners Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $146.00 - Stock Observer

Crossmark Global Holdings Inc. Buys 23,719 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Price Target Cut to $146.00 by Analysts at Leerink Partners - Daily Political

Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Daily Political

Gilead Sciences (NASDAQ:GILD) Stock Rating Lowered by Wall Street Zen

Gilead Sciences (GILD) Margin Surge Tests Cautious Growth Narratives After FY 2025 Results

RBC Capital Reaffirms Their Hold Rating on Aardvark Therapeutics, Inc. (AARD)

Prothena (PRTA) Gets a Hold from RBC Capital

Gilead Earnings: Strong HIV Growth Counters CAR-T Weakness, but Anito-Cel Launch in Focus | Morningstar

GILD Maintained by RBC Capital -- Price Target Lowered to $122

Gilead Sciences (NASDAQ:GILD) Price Target Cut to $122.00 by Analysts at Royal Bank Of Canada

Gilead Sciences, Inc. (NASDAQ:GILD) Plans Quarterly Dividend of $0.82

Virtus Family Office LLC Buys New Shares in Gilead Sciences, Inc. $GILD

Gilead Sciences Raises 2026 Sales Forecast Amid Acquisition Costs, ETPharma

Gilead Sciences (GILD) Announces Quarterly Dividend and Adjusts 2026 Outlook

Gilead Sciences, Inc. $GILD Shares Sold by Patton Albertson Miller Group LLC - Zolmax

Gilead Sciences, Inc. (NASDAQ:GILD) to Issue Quarterly Dividend of $0.82 - Stock Observer

Gilead Sciences (GILD) Stock Drops Despite Q1 Beat on Massive Acquisition Charges

Gilead Sciences, Inc. $GILD Holdings Decreased by GRIMES & Co WEALTH MANAGEMENT LLC

Gilead Sciences (GILD) Reports Strong Q1 2026 Earnings and Raises Sales Guidance

Gilead Sciences, Inc. $GILD Shares Sold by Patton Albertson Miller Group LLC - Daily Political

Gilead Sciences Q1 Earnings Call Highlights

Gilead Sciences (NASDAQ:GILD) Issues Quarterly Earnings Results

Diagnosing and defining MASLD in people living with chronic hepatitis B

Gilead Sciences Inc. Reports Advance In Q1 Income

Gilead Sciences (NASDAQ:GILD) Issues FY 2026 Earnings Guidance

Gilead Sciences (NASDAQ:GILD) Releases FY 2026 Earnings Guidance - Daily Political

Gilead Sciences shares decline 1.36% ahead of first quarter earnings

A Look At Gilead Sciences (GILD) Valuation After FDA Priority Review For New HIV Tablet

WealthShield Partners LLC Makes New $1.73 Million Investment in Gilead Sciences, Inc. $GILD - Stock Observer

Indivisible Partners Purchases New Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences News | Markets Insider

Galapagos rapporteert financiële resultaten over het eerste kwartaal van 2026 en geeft bedrijfsupdate

Gilead Case Could Reshape Drug Liability: California Brief

Swedbank AB Grows Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences, Inc. $GILD Shares Sold by Sprucegrove Investment Management Ltd.

Equitable Trust Co. Has $6.07 Million Holdings in Gilead Sciences, Inc. $GILD

Mitsubishi UFJ Asset Management Co. Ltd. Has $330.64 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

GILEAD SCIENCES, INC. Reduces Stake in Arcellx Inc by 6,720,703 Shares

RNC Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

Morse Asset Management Inc Invests $1.22 Million in Gilead Sciences, Inc. $GILD

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain - Yahoo News Canada

Gilead Sciences, Inc. $GILD Shares Acquired by M&T Bank Corp

Gilead Sciences, Inc. $GILD Shares Purchased by QRG Capital Management Inc. - Stock Observer

Alliance Wealth Advisors LLC UT Cuts Stake in Gilead Sciences, Inc. $GILD